Correction to: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons (Molecular Neurodegeneration, (2024), 19, 1, (88), 10.1186/s13024-024-00779-9)

Links

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85212689186&doi=10.1186%2Fs13024-024-00791-z&partnerID=40&md5=a0d6ad7dc543835c5d838e56b92e0d1e

DOI

https://doi.org/10.1186/s13024-024-00791-z
Final published version

J. Jones-Tabah
K. He
N. Karpilovsky
K. Senkevich
G. Deyab
I. Pietrantonio
T. Goiran
Y. Cousineau
T. Goldsmith
E. del Cid-Pellitero
C.X.Q. Chen
W. Luo
Z. You
N. Abdian
J. Ahmad
J.A. Ruskey
F. Asayesh
D. Spiegelman
S. Fahn
C. Waters
O. Monchi
Y. Dauvilliers
N. Dupré
I. Miliukhina
A. Timofeeva
A. Emel’yanov
L. Greenbaum
S. Hassin-Baer
R.N. Alcalay
A. Milnerwood
T.M. Durcan
Z. Gan-Or
E.A. Fon

The authors wish to note the Grant ID, MFFF – 007905 relating to the mentioned grants to ZGO and EAF from the Michael J. Fox Foundation which was mistakenly omitted from the original article [1]. The authors also wish to note that Lior Greenbaum is only affiliated to affiliation #14 (Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel). © 2024 Elsevier B.V., All rights reserved.

Original language	English
Journal	Molecular Neurodegeneration
Volume	19
Issue number	1
DOIs	https://doi.org/10.1186/s13024-024-00791-z
State	Published - 2024

Research areas

animal experiment, controlled study, drug therapy, erratum, human, therapy, clinical article, etiology, human cell

ID: 143370467